コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 the neurovascular unit (NVU) that result in brain edema.
2 by seizures, can initiate symptomatic focal brain edema.
3 n as a novel therapeutic option in vasogenic brain edema.
4 al pressure, cerebral perfusion pressure and brain edema.
5 gittal sinus values concomitant with diffuse brain edema.
6 Mild hypothermia delays ammonia-induced brain edema.
7 on of new therapeutic approaches to treating brain edema.
8 yamines and regional cerebral blood flow and brain edema.
9 ea of incomplete ischemia that is developing brain edema.
10 nal fluid, osmoregulation, and regulation of brain edema.
11 experimental model of vasogenic peritumoral brain edema.
12 his 'glymphatic' system to the main types of brain edema.
13 ing and provide treatment for post-traumatic brain edema.
14 ease of blood-brain barrier permeability and brain edema.
15 tcome in clinical conditions associated with brain edema.
16 ating intracranial hypertension and reducing brain edema.
17 9 (MMP-9) contributes to the pathogenesis of brain edema.
18 reducing inflammatory cell infiltration and brain edema.
19 es, extensive loss of myelinated tracks, and brain edema.
20 owever, RSG reduced neither IgG staining nor brain edema.
21 a similar extent as LPS and also exacerbated brain edema.
22 acterized by cardiac, pulmonary, kidney, and brain edema.
23 in infarct volume (59% to 69%; P:<0.003) and brain edema (50% to 61%; P:<0.05), eliminated brain infi
30 neuronal loss in conjunction with attenuated brain edema after cerebral contusion and to reduce brain
33 inhibition by SR49059 significantly reduced brain edema after cortical contusion injury (CCI) in rat
36 ntly reduced neurodeficits and perihematomal brain edema after ICH induction by injection of either a
39 evere signs of cerebral malaria with greater brain edema, although disruption of the blood-brain barr
47 duced inflammation, consequently attenuating brain edema and improving of neurological functions afte
48 effective in attenuating short-term effects (brain edema and infarct volume) or long-term effects (br
49 of VEGF reduces ischemia/reperfusion-related brain edema and injury, implicating VEGF in the pathogen
52 mbolic models of stroke in rats, and reduced brain edema and neuronal loss after traumatic brain inju
53 to investigate 1) the effect of mannitol on brain edema and oxygenation, using a multiparametric mag
54 contrast to the slowed diffusion produced by brain edema and seizure activity, diffusion in the ECS w
55 receiving the 28% polymers developed severe brain edema and seizures, and accrual to this cohort was
56 neuroprotection by furosemide indicate that brain edema and swelling are essential events in the bra
57 ood on hematoma volume, neurologic function, brain edema and swelling, and markers of neuroinflammati
60 2X7R siRNA alleviated neurological deficits, brain edema, and BBB disruption after ICH, in associatio
63 suppression prevented neurological deficits, brain edema, and Evans blue extravasation at 24 to 72 ho
64 n decreases neutrophil infiltration, reduces brain edema, and improves neurological function in an in
65 significantly (P<0.05) reduced BBB leakage, brain edema, and ischemic lesion volume compared with ra
66 imals showed blood-brain barrier disruption, brain edema, and neurologic deficits, accompanied with p
67 essed the effects of isosal on hemodynamics, brain edema, and plasma sodium concentration after head
68 ving rapid water transport such as glaucoma, brain edema, and swelling of premature infant lungs.
69 f slow controlled rewarming to avoid rebound brain edema, and the high risk for infectious and cardio
72 microvascular hyperpermeability followed by brain edema are hallmark features of several brain patho
74 rized by breakdown of cerebellum and cortex, brain edema, astrocytosis, degeneration of neuronal dend
75 cantly improved neurobehavioral function and brain edema at 24 hrs but not 72 hrs after subarachnoid
80 analysis showed the PAI-1 treatment reduced brain edema, axonal degeneration, and cortical cell deat
82 flammatory changes, however, did not improve brain edema, BBB disruption and neurological outcomes af
83 Outcomes measured included mortality rate, brain edema, BBB disruption, and neurobehavioral testing
84 s in an acute setting, specifically in fatal brain edema (BE) associated with DKA, we studied neurona
86 patients who died as the result of clinical brain edema(BE)that developed during the treatment of se
88 lt in post-operative complications including brain edema, blood-brain barrier disruption (BBB) and ce
89 treatment group showed significantly reduced brain edema, blood-brain barrier disruption, lesion volu
90 e killed at 4, 8 and 24 h later and used for brain edema, blood-brain barrier permeability, hemorrhag
95 blood-brain barrier (BBB) permeability, yet brain edema does not normally occur during pregnancy.
96 layed cooling for the treatment of cytotoxic brain edema does not provide definitive or lasting treat
99 urological deficits, Fluoro-Jade C staining, brain edema, Evans blue extravasation and fluorescence,
100 ith fulminant hepatic failure (FHF) die with brain edema, exhibiting an increased cerebral blood flow
102 AQP4-deficient mice showed reduced cellular brain edema following water intoxication and ischemic st
103 factor for the development of infarction by brain edema formation and apoptotic neuronal cell death
104 t of the selective COX-2 inhibitor NS-398 on brain edema formation and cerebral blood flow in a rat m
105 in mouse brain and to evaluate its effect on brain edema formation and infarction after permanent foc
106 animals demonstrate reproducible hematomas, brain edema formation and marked neurological deficits.
107 turation and in brain tissue PO(2) alongside brain edema formation and microvascular lumen collapse a
108 ategy might help to attenuate trauma-induced brain edema formation and neuronal damage as secondary e
109 ctive effects of thrombin preconditioning on brain edema formation are related to this activation.
113 ion of a low dose of thrombin attenuates the brain edema formation that results from either an intrac
114 or agonist, biphalin, in decreasing reducing brain edema formation using both in vitro and in vivo mo
116 arterial blood pressure aggravates regional brain edema formation, regional cell death, and neurolog
120 Three days after intracerebral hemorrhage, brain edema, hematoma volume and the number of apoptotic
121 in injuries, such as brain trauma, localized brain edema, hematoma, focal cerebral ischemia, or brain
123 rovide a new therapeutic option for reducing brain edema in a wide variety of cerebral disorders.
124 molecular mechanism for the pathogenesis of brain edema in acute bacterial meningitis, and suggest t
127 a) represents a significant component of the brain edema in ALF, and elevated blood and brain ammonia
130 tion of lipopolysaccharide (LPS) exacerbates brain edema in cirrhotic rats; and if so whether this is
132 "reverse urea effect" in the pathogenesis of brain edema in DDS.DWI may be a useful diagnostic tool f
138 e, a commonly used glucocorticoid to prevent brain edema in GBM patients, suppressed the observed inf
140 We did not observe astrocyte swelling or brain edema in the acute phase, calling into question cu
141 y (p<0.001), and significantly reduced focal brain edema in the cortex adjacent to the site of maxima
143 iation of sodium and potassium with ischemic brain edema in the rodent model, and show that these cla
145 ld hypothermia in a model of ammonia-induced brain edema in which accumulation of brain glutamine has
146 intracerebral hemorrhage (ICH) indicate that brain edema increases progressively in the first 24 h an
150 ssment included neurological function tests, brain edema measurement, Evans blue extravasation, immun
152 correlated with significant improvements in brain edema, motor coordination, and working memory, and
153 We investigated the role of VEGF165b in brain edema, neutrophil infiltration, ischemic brain dam
154 poorly controlled type 1 diabetes and fatal brain edema of ketoacidosis neuronal deficits associated
155 visceral hypoxic injuries), visualization of brain edema on MR images, and T1 and T2 relaxation times
159 ccount for differences in the development of brain edema seen in acute or chronic liver failure.
160 sults showed that mTBI model did not produce brain edema, skull fracture or sensorimotor coordination
161 igate the role of AQP4 in meningitis-induced brain edema, Streptococcus pneumoniae was injected into
163 is crucial for fluid clearance in vasogenic brain edema, suggesting AQP4 activation and/or up-regula
164 (thrombin preconditioning; TPC) reduces the brain edema that follows a subsequent intracerebral infu
165 e sought to define the mechanism controlling brain edema through the use of the murine experimental c
167 ffect of recombinant human erythropoietin on brain edema using diffusion-weighted magnetic resonance
172 razolium chloride (TTC) staining at 24 h and brain edema was measured using the wet/dry weight method
173 n GCSF vs. control; however no difference in brain edema was observed at 24 hrs after injury between
177 of alterations of CBF on the development of brain edema, we administered intravenous (IV) indomethac
183 wmetry and specific gravity, an indicator of brain edema, were measured in contralateral (non-ischemi
185 thioacetamide caused a significant degree of brain edema, which was associated with induction of OS a
187 improved cardiac resuscitability and reduced brain edema, without increasing bleeding complications.
188 ence for enhanced ECS diffusion in vasogenic brain edema, yet greatly slowed diffusion in cytotoxic e
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。